898 Intratumoral administration of NL-201, an alpha-independent IL-2/15 receptor agonist, inhibits the growth of both injected and uninjected tumors in preclinical models

• Kevin Yu,
• Ryan Swanson,
• Carl Walkey,
• Justin Huard,
• Laurie Tatalick,
• Marianne Riley

Affiliations

Kevin Yu

3 Computer Aided Medical Procedures, The Johns Hopkins University, Baltimore, Maryland, USA

Ryan Swanson

Aff688 Alpine Immune Sciences Seattle WA USA

Carl Walkey

2Neoleukin Therapeutics Inc, Seattle, WA, USA

Justin Huard

Neoleukin Therapeutics, Inc., Seattle, WA, United States

Laurie Tatalick

Neoleukin Therapeutics, Inc., Redmond, WA, USA

Marianne Riley

Neoleukin Therapeutics, Inc., Redmond, WA, USA